Clinical Trial Update: Tipifarnib in Treating Patients With Anemia or Neutropenia and Large Granular Lymphocyte Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tipifarnib in patients with anemia or neutropenia and large granular lymphocytic leukemia, including chronic lymphocytic leukemia in st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• T-cell Large Granular Lymphocytic Leukemia

Drugs mentioned

• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage III Chronic Lymphocytic Leukemia, Stage IV Chronic Lymphocytic Leukemia | Phase 2 | Status: TERMINATED